This company is no longer active
Resumen de acción ZSAN.Q
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 3 riesgos adicionales
Competidores de Zosano Pharma Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0007 |
| 52 Week High | US$24.80 |
| 52 Week Low | US$0.0001 |
| Beta | 2.73 |
| 1 Month Change | 133.33% |
| 3 Month Change | -99.45% |
| 1 Year Change | -100.00% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Noticias y actualizaciones recientes
Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02
Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13Rentabilidad de los accionistas
| ZSAN.Q | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 40.0% | 0.04% | 0.7% |
| 1Y | -100.0% | -0.9% | 23.9% |
Rentabilidad vs. Industria: ZSAN.Q underperformed the US Medical Equipment industry which returned -22.2% over the past year.
Rentabilidad vs. Mercado: ZSAN.Q underperformed the US Market which returned -20.2% over the past year.
Volatilidad de los precios
| ZSAN.Q volatility | |
|---|---|
| ZSAN.Q Average Weekly Movement | 4,827.6% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: ZSAN.Q's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: ZSAN.Q's weekly volatility has increased from 2395% to 4789% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2006 | 40 | Steven Lo | www.zosanopharma.com |
Resumen de fundamentos de Zosano Pharma Corporation
| Estadísticas fundamentales de ZSAN.Q | |
|---|---|
| Capitalización bursátil | US$3.43k |
| Beneficios(TTM) | -US$55.19m |
| Ingresos (TTM) | US$659.00k |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está ZSAN.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ZSAN.Q | |
|---|---|
| Ingresos | US$659.00k |
| Coste de los ingresos | US$20.85m |
| Beneficio bruto | -US$20.19m |
| Otros gastos | US$35.01m |
| Beneficios | -US$55.19m |
Últimos beneficios comunicados
Mar 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -11.26 |
| Margen bruto | -3,063.13% |
| Margen de beneficio neto | -8,375.11% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado ZSAN.Q a largo plazo?
Ver rendimiento histórico y comparativa